Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

The Effects of In-phase Bilateral Exercise in People with Progressive Multiple SclerosisCompleted
NCT06436131NAUpdated Sep 19, 2024
Sponsor: Cyprus University of Technology
Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Secondary Progressive
Cyprus
Using Patient-Reported Outcomes To Improve the Care of People With Multiple SclerosisCompleted
NCT04979546NAUpdated Sep 19, 2024
Sponsor: University of Alberta
Multiple Sclerosis · Anxiety · Depression · Patient Satisfaction
Canada
Measuring Consequences of Disability for Patients With Multiple Sclerosis and Caregivers on Economic BurdenCompleted
NCT02592265N/AUpdated Sep 19, 2024
Sponsor: Lille Catholic University
Multiple Sclerosis · Physical Disability · Economic Burden · Social Interaction
Reducing Sedentary Behaviour: A Novel Opportunity for Managing Comorbidity in MS?Completed
NCT03136744NAUpdated Sep 19, 2024
Sponsor: University of Alberta
Multiple Sclerosis
Canada
A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple SclerosisCompleted
NCT06588387N/AUpdated Sep 19, 2024
Sponsor: Novartis
Secondary Progressive Multiple Sclerosis
United States
Multiple Sclerosis-Simvastatin Trial 2Completed
NCT03387670Phase 3Updated Sep 19, 2024
Sponsor: University College, London
Secondary Progressive Multiple Sclerosis (SPMS)
United Kingdom
The Effect of Nurse Practitioner (NP-led) Care Upon Mood in People With Multiple SclerosisCompleted
NCT04388592NAUpdated Sep 19, 2024
Sponsor: University of Alberta
Multiple Sclerosis · Nurse's Role
Canada
Neurodegenerative Diseases Progression Markers (MARKERS-NDD)Recruiting
NCT06596746N/AUpdated Sep 19, 2024
Sponsor: Casa di Cura San Raffaele Cassino
Neurodegenerative Diseases · Parkinson Disease · Synucleinopathies · Lewy Body Disease
Italy
Ultra-high-field Brain MRI in Multiple SclerosisCompleted
NCT05718947N/AUpdated Sep 19, 2024
Sponsor: Zuyderland Medisch Centrum
Multiple Sclerosis
Netherlands
Validation of Multimodal Evoked Potentials (mmEP) for Predicting Disease Progression in Multiple SclerosisCompleted
NCT03632473N/AUpdated Sep 19, 2024
Sponsor: University Hospital, Basel, Switzerland
Multiple Sclerosis
Switzerland
Evaluating the Efficacy and Safety of Transitioning Patients From Natalizumab to OcrelizumabCompleted
NCT03157830N/AUpdated Sep 19, 2024
Sponsor: Providence Health & Services
Relapsing Remitting Multiple Sclerosis
United States
Enhancing Pelvic Floor Function With Transcranial Magnetic and Tibial Nerve Stimulation for Neurogenic Bladder in MSNot Yet Recruiting
NCT06581341NAUpdated Sep 3, 2024
Sponsor: Sierra Varona SL
Neurogenic Overactive Bladder · Multiple Sclerosis
Upper Extremity Motor Imagery Functional Skills and Quality of Life in Patients With Multiple SclerosisCompleted
NCT06572059N/AUpdated Aug 29, 2024
Sponsor: Kahramanmaras Sutcu Imam University
Multiple Sclerosis · Upper Extremity Problem · Quality of Life · Image, Body
Turkey (Türkiye)
Virtual Reality in the Treatment of Pelvic Floor Dysfunction in Women With Multiple SclerosisNot Yet Recruiting
NCT06576947NAUpdated Aug 29, 2024
Sponsor: Universidad de Almeria
Multiple Sclerosis
Safety and Effectiveness of Generic Fingolimod (Sphingomod®, Hikma) in Patients With Relapsing-Remitting Multiple Sclerosis in EgyptCompleted
NCT05423769N/AUpdated Aug 23, 2024
Sponsor: Hikma Pharmaceuticals LLC
Relapsing-Remitting Multiple Sclerosis
Egypt
Positive Psychological Interventions for Patients With Multiple SclerosisUnknown
NCT06500039NAUpdated Aug 22, 2024
Sponsor: Abant Izzet Baysal University
Multiple Sclerosis
Turkey (Türkiye)
Safety and Efficacy of Fecal Microbiota TransplantationRecruiting
NCT04014413NAUpdated Aug 22, 2024
Sponsor: Chinese University of Hong Kong
Crohn Disease · Ulcerative Colitis · Celiac Disease · Irritable Bowel Syndrome
Hong Kong
Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the NetherlandsRecruiting
NCT06567197N/AUpdated Aug 22, 2024
Sponsor: Amsterdam UMC, location VUmc
Multiple Sclerosis, Relapsing-Remitting
Netherlands
The MS-LINK™ Outcomes StudyCompleted
NCT04735406N/AUpdated Aug 22, 2024
Sponsor: EMD Serono Research & Development Institute, Inc.
Multiple Sclerosis
United States
Neural Mobilization on Multiple SclerosisCompleted
NCT06153264NAUpdated Aug 21, 2024
Sponsor: Kahramanmaras Sutcu Imam University
Multiple Sclerosis
Turkey (Türkiye)
Calorie Restriction in Multiple SclerosisActive Not Recruiting
NCT04042415NAUpdated Aug 20, 2024
Sponsor: Federico II University
Multiple Sclerosis, Relapsing-Remitting · Caloric Restriction
Italy
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis ComplexCompleted
NCT02849457Phase 2Updated Aug 19, 2024
Sponsor: Martina Bebin
Tuberous Sclerosis Complex
United States
Non-invasive Electrical Spinal Cord Stimulation To Restore Upper Extremity Function in Multiple SclerosisRecruiting
NCT06552611Phase 1Updated Aug 14, 2024
Sponsor: University of Washington
Multiple Sclerosis
United States
A Phase IIIb, Multicenter, International Study to Evaluate the Efficacy, Safety and Tolerability of EK-12 in Patients With RRMSTerminated
NCT03283397Phase 3Updated Aug 13, 2024
Sponsor: Bosnalijek D.D
Multiple Sclerosis, Relapsing-Remitting
Turkey (Türkiye)
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple SclerosisUnknown
NCT04742400Phase 2Updated Aug 13, 2024
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Multiple Sclerosis
United States

Previous page Next page